INTERVIEW: Isis CEO Crooke on antisense progress
This article was originally published in Scrip
Executive Summary
Isis Pharmaceuticals is the grandfather of commercial antisense drug development as the only company to date to bring an antisense oligonucleotide (ASO) to market since it was founded more than 24 years ago by CEO and chairman Stanley Crooke.